Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125864521 | 12586452 | 1 | I | 2016 | 20160713 | 20160725 | 20160725 | PER | US-BAYER-2016-138630 | BAYER | 91.00 | YR | E | F | Y | 61.22000 | KG | 20160725 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125864521 | 12586452 | 1 | PS | CLARITIN | LORATADINE | 1 | Oral | 1 DF, QD | N | CVM02CJ | 19658 | 1 | DF | TABLET | QD | ||||
125864521 | 12586452 | 2 | C | METOPROLOL. | METOPROLOL | 1 | UNK | 0 | |||||||||||
125864521 | 12586452 | 3 | C | BIOTIN | BIOTIN | 1 | UNK | 0 | |||||||||||
125864521 | 12586452 | 4 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | UNK | 0 | |||||||||||
125864521 | 12586452 | 5 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125864521 | 12586452 | 1 | Seasonal allergy |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125864521 | 12586452 | Eye irritation | |
125864521 | 12586452 | Lacrimation increased | |
125864521 | 12586452 | Rhinorrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125864521 | 12586452 | 1 | 20160713 | 0 |